Results 231 to 240 of about 87,366 (344)

Comparison of the effects of non-calcium and calcium-based phosphate binders on fibroblast growth factor-23 levels in patients with CKD–mineral and bone disorder: a meta-analysis of randomized controlled trials

Seunghyun Cha, Minyoung Baek, Choungwon Jung, Hyunah Kim   +3 more
openalex   +1 more source

DIETARY PHOSPHOROUS INTAKE AMONG HAEMODIALYSIS PATIENTS IN RELATION TO DOSAGE OF PHOSPHATE BINDERS AND HYPERPHOSPHATEMIA.

, 2012
RD Camilla Cameron, Agneta Andersson, Gerd Faxén Irving   +2 more
openalex   +1 more source

The adsorption of veterinary drugs to mycotoxin binders in a feed-containing buffered matrix [PDF]

, 2016
Croubels, Siska, De Backer, Patrick, De Mil, Thomas, Devreese, Mathias   +3 more
core   +1 more source

ALDOA Promotes Glycolysis and NLRP3/GSDMD Pyroptosis to Accelerate ALS Progression

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Amyotrophic lateral sclerosis (ALS) is characterized by progressive motor neuron degeneration. Glycolytic dysregulation is implicated in disease progression, yet the underlying mechanisms remain unclear. This study investigates how Aldolase A (ALDOA) drives ALS progression through glycolysis‐mediated motor neuron pyroptosis.
Kaixin Yan, Yan Jiang, Yuxuan Yong, Tianshuo Zhang, Niannian Zhang, Qianqian Zeng, Xue Gong, Li Meng, Fangfang Bi, Yongmin Liu   +9 more
wiley   +1 more source

FP466INTERACTION BETWEEEN PHOSPHATE BINDERS, VITAMIN K AND VASCULAR CALCIFICATION, IN A CROSS OVER STUDY [PDF]

, 2019
Aegida Neradová, Bastiaan van Dam, Leon J. Schurgers, Marc Vervloet   +3 more
openalex   +1 more source

A Systematic Comparison of Alpha‐Synuclein Seed Amplification Assays for Increasing Reproducibility

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Seed amplification assays (SAAs) enable ultrasensitive detection of misfolded α‐synuclein across biofluids and tissues. Yet, heterogeneity in protocols limits cross‐study comparability and clinical translation. Here, we review α‐synuclein SAA methods and their performance across various biological matrices.
Manuela Amaral‐do‐Nascimento, Daniela F. Santos, Tuane C. R. G. Vieira, Tiago F. Outeiro   +3 more
wiley   +1 more source

Is It Too Much of a Good Thing? A New Era in Phosphate Binder Therapy in ESRD. [PDF]

J Am Soc Nephrol, 2015
Qunibi WY.
europepmc   +1 more source

Incorporation of Selenium into Sol–Gel‐Derived Bioactive Glass: Influence on Glass Structure, Bioactivity, and its Selective Cytotoxicity

Advanced Engineering Materials, EarlyView.
Selenium was incorporated into a sol–gel‐derived bioactive glass to enable sustained therapeutic ion release. The selenium‐containing glass preserved bioactivity while selectively inducing cytotoxicity in osteosarcoma cells and maintaining osteoblastic viability.
Breno Rocha Barrioni, Thalita Marcolan Valverde, Talita Martins, Guilherme Mattos Jardim Costa, Alfredo Miranda de Goes, Marcello Rosa Dumont, Eduardo Henrique Martins Nunes, Marivalda de Magalhães Pereira   +7 more
wiley   +1 more source

Serum Phosphorus Management with Sucroferric Oxyhydroxide as a First-Line Phosphate Binder within the First Year of Hemodialysis.

Am J Nephrol
Medaura JA, Zhou M, Ficociello LH, Anger MS, Sprague SM.   +4 more
europepmc   +1 more source

IRON STORES ARE INCREASED WITHIN THE FIRST 24 WEEKS AND MAINTAINED FOR 80 ADDITIONAL WEEKS WITH LONG-TERM USE OF ORAL FERRIC CITRATE (FC) AS A PHOSPHATE BINDER

, 2015

openalex   +1 more source